Successful Remission in Ulcerative Colitis Patients Achieved Using Combination Therapy

Successful Remission in Ulcerative Colitis Patients Achieved Using Combination Therapy
In a new study entitled “Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis,” a team of researchers investigated if a combined therapy of adalimumab with granulocyte and monocyte adsorptive apheresis offers benefits when administered to patients with refractory ulcerative colitis who failed to respond to conventional therapies (corticosteroids,

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *